---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-008608"
form_type: "8-K"
ticker: "HCA"
cik: "0000860730"
company_name: "HCA Healthcare, Inc."
filed_at: "2025-01-24T23:59:59+00:00"
generated_at: "2026-05-27T12:35:33.766858+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# HCA Q4 revenue $18.3B, EPS $5.63; 2025 EPS guidance $24.05-$25.85; $10B buyback authorized

## Summary
- Q4 revenue $18.285B (+5.7% YoY); net income $1.438B ($5.63 diluted EPS) vs $1.607B ($5.93) in 4Q23; includes $0.60/sh hurricane impact.
- Adjusted EBITDA Q4 $3.712B vs $3.618B; same-facility admissions +3.0%, equivalent admissions +3.1%.
- Full year 2024 revenue $70.6B, net income $5.76B ($22.00 EPS) vs $5.24B ($18.97) in 2023; Adjusted EBITDA $13.88B.
- 2025 guidance: revenue $72.8-$75.8B, net income $5.85-$6.29B, EPS $24.05-$25.85, capex $5.0-$5.2B.
- Board authorized $10B share repurchase; quarterly dividend $0.72/share payable Mar 31 to record Mar 17.

## SEC filing metadata
- accession: 0000950170-25-008608
- form_type: 8-K
- ticker: HCA
- cik: 0000860730
- company_name: HCA Healthcare, Inc.
- filed_at: 2025-01-24T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/860730/000095017025008608/0000950170-25-008608-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/860730/000095017025008608/hca-20250124.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-008608
- JSON: https://secwatch.observer/filing/0000950170-25-008608.json
- Plain text: https://secwatch.observer/filing/0000950170-25-008608.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.